Loading provider…
Loading provider…
Hematology & Oncology Physician in Washington, DC
NPI: 1558455378Primary Practice Location
MEDSTAR GEORGETOWN UNIVERSITY HOSPITAL
3800 Reservoir Rd NW, Washington, DC
Primary Employer
Mgmc, LLC
mgmcltd.co.uk
HQ Phone
Get MBBS, MD, MPH George's Phone NumberMobile
Get MBBS, MD, MPH George's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardVT State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 134 | 307 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 87 | 321 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 56 | 56 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 22 | 26 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 15 | 15 |
STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer.
Authors: Taber, Ann, Park, Youngrok, Lelo, Alana, Prip, Frederik, Xiao, Jerry, Berry, Deborah L, Chaldekas, Krysta, Jensen, Jørgen Bjerggaard, Philips, George, Kim, Jung-Sik, Harris, Brent T, Dyrskjøt, Lars, Waldman, Todd
Journal: Urol Oncol
Publication Date: 2021-03-10
Is interleukin 2 the best initial therapy for many patients with metastatic renal cell carcinoma?
Authors: Philips, George, Atkins, Michael B
Journal: Cancer J
Continuous culture of urine-derived bladder cancer cells for precision medicine.
Authors: Jiang, Shuai, Wang, Jiaqi, Yang, Chen, Tan, Renke, Hou, Jun, Shi, Yuan, Zhang, Huihui, Ma, Shiyu, Wang, Jianan, Zhang, Mengmeng, Philips, George, Li, Zengxia, Ma, Jian, Yu, Wanjun, Wang, Guohua, Wu, Yuanming, Schlegel, Richard, Wang, Huina, Cao, Shanbo, Guo, Jianming, Liu, Xuefeng, Dang, Yongjun
Journal: Protein Cell
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, OTHER: Pharmacological Study, PROCEDURE: Biospecimen Collection, OTHER: Clinical Observation, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: Cystoscopy, PROCEDURE: CT Urography
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Gemcitabine Hydrochloride, DRUG: Eribulin Mesylate
Lead Sponsor: Weill Medical College of Cornell University
Collaborators: United States Department of Defense
Intervention / Treatment: DRUG: 111In-J591, DRUG: Hydrocortisone, DRUG: Ketoconazole, DRUG: 177Lu-J591